Industry NewsProBioGen and Pionyr Immunotherapeutics Initiate a Second Immuno-Oncology Development Project
Editorial ArticleCombating the World’s Deadliest Viruses – Harnessing Virus-like Particles as Vaccines
Editorial ArticleState-of-the-Art Cellular Screening Facility Enables Efficient Drug Discovery for Academic Labs